PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-04-30

Date Title Company
30-Apr-2025 GLG Life Tech Corporation Reports 2024 Annual & Fourth Quarter Financial Results ACCESS Newswire
30-Apr-2025 Justera Health Announces Director Resignation and Change to Fiscal Year End ACCESS Newswire
30-Apr-2025 Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on 2025 Developments ACCESS Newswire
30-Apr-2025 BODYWELLE Med Spa in Miami Beach to Host Free EMSculpt & Strengthen Event Featuring Emsculpt NEO on May 3 ACCESS Newswire
30-Apr-2025 Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network ACCESS Newswire
30-Apr-2025 Bausch Health Announces First Quarter 2025 Results ACCESS Newswire
30-Apr-2025 AtlantiCare Teams Up With Egg Harbor Family Dental to Expand Senior Services ACCESS Newswire
30-Apr-2025 BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservative development for the second half of the fiscal year 2024/25 BRAIN Biotech AG
30-Apr-2025 BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47) BlackfinBio
30-Apr-2025 CellProthera to Present ProtheraCytes® Clinical Data and Receive a Stem Cell Engineering Abstract Award for Phase I/IIb Results at ISCT 2025 Scientific Annual Meeting in New Orleans CellProthera
30-Apr-2025 CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy CSL Vifor and Travere Therapeutics
30-Apr-2025 Cycuria Therapeutics Launches with the Formation of a Distinguished Advisory Board and Significant Public Grant Funding Cycuria Therapeutics
30-Apr-2025 Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC Johnson & Johnson’s
30-Apr-2025 Novo Nordisk Foundation expands Challenge Programme outside of Denmark for the first time and significantly increases grants Novo Nordisk
30-Apr-2025 OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain OKYO Pharma
30-Apr-2025 Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France Olon Group
30-Apr-2025 'Road to Pro' Campaign Shows How Rising College Stars Stay Game-Ready with sam(R) ACCESS Newswire
30-Apr-2025 EVERSANA Strengthens Position as a Leading 3PL & Channel Provider with New 358,000 Square Foot Distribution Center, Expanded Cold Chain Capabilities, Enhanced Warehouse Management System and AI-Powered Robotics EVERSANA
30-Apr-2025 Digital Inclusion Under the Microscope as Digital Poverty Alliance launches NHS Sector Inquiry The Digital Poverty Alliance (DPA)
30-Apr-2025 IFS Maven Equity Finance and the Scottish National Investment Bank back NCIMB with £1.7 million investment to drive growth NCIMB Limited